Types of Cancer We Treat

Breast Cancer

We build your team of breast cancer experts based on your needs, providing personalized, compassionate care.

First, we identify the specific type of breast cancer using microscopic analysis, genetic testing, and imaging. Then, we create an individualized treatment plan for you. We provide the most advanced treatments, such as breast-conserving surgery and targeted drugs, and our researchers evaluate promising new treatments for breast cancer in clinical trials.

We offer comprehensive support services, including fertility preservation counseling, psychological support, and integrative therapies.

We counsel women who are at high risk for developing breast cancer, and our experts frequently provide second opinions.

Meet Our Doctors
Dr. Sylvia Adams
Our Approach to Breast Cancer Treatment Our Approach to Breast Cancer Treatment
Diagnosis
Breast Cancer Diagnosis
Surgery
Breast Cancer Surgery
Breast Reconstruction
Breast Cancer Breast Reconstruction
Chemotherapy & Other Systemic Therapies
Breast Cancer Chemotherapy & Other Systemic Therapies
Radiation Therapy
Breast Cancer Radiation Therapy

Related News

New Treatment Helps Fight Triple-Negative Breast Cancer
Read Story
Options for Managing an Increased Risk of Breast Cancer
Read Story
Health Systems on Long Island Expand Cancer Care Programs
Read Story
Patient Navigates Healthcare Disparities with Expert
Read Story
The Genetic Link in Triple-Negative Breast Cancer Explained
Read Story
Immunotherapy Provides New Options for Advanced Cancers
Read Story
Dr. Freya Schnabel Discusses Advances in Breast Cancer
Read Story
One Young Woman’s Journey to a Double Mastectomy
Read Story
Breast Surgeons Discuss ‘Going Flat’ After Mastectomy
Read Story
Breast in a Day Provides Faster Double Mastectomy Recovery
Read Story
New Device Reduces Breast Cancer Surgeries
Read Story
Fat Tissue Helps Screen for Invasive Breast Cancer
Read Story

Clinical Trials and Research Studies

Phase 1/2

A PHASE Ib/II OPEN-LABEL MULTICENTER RANDOMIZED UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MORPHEUS-TNBC)

Learn More

Phase 2

PRECISION (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer.

Learn More

Phase 1

Phase 1b Open-label Study of MK-7162 in Combination with Pembrolizumab (MK-3475) +/- other therapies in Participants with Advanced Solid Tumors

Learn More

Phase 1

A Phase 1 Open-Label Multicenter Study to Assess the Safety Tolerability and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors

Learn More
View All Related Clinical Trials (19)